Literature DB >> 2179424

Hemagglutinin, urease, and hemolysin production by Proteus mirabilis from clinical sources.

H L Mobley1, G R Chippendale.   

Abstract

Proteus mirabilis, a common cause of urinary tract infection, can lead to serious complications including pyelonephritis. Adherence factors, urease, and hemolysin may be virulence determinants. These factors were compared for bacteria cultured from 16 patients with acute pyelonephritis and 35 with catheter-associated bacteriuria and for 20 fecal isolates. Pyelonephritis isolates were more likely (P less than .05) to express the mannose-resistant/Proteus-like (MR/P) hemagglutinin in the absence of mannose-resistant/Klebsiella-like (MR/K) hemagglutinin than were catheter-associated or fecal isolates. Pyelonephritis isolates produced urease activity of 63 +/- 27 (mean +/- SD) mumol of NH3/min/mg of protein, not significantly different from catheter-associated or fecal isolates. Hybridization of Southern blots of P. mirabilis chromosomal DNA with two urease gene probes demonstrated that urease gene sequences were conserved in all isolates. Geometric mean of reciprocal hemolytic titers for pyelonephritis isolates was 27.9; for urinary catheter isolates, 18.0; and for fecal isolates, 55.7 (not significantly different, P greater than .1). Although in vivo expression of urease and hemolysin may not be reliable indexes of virulence, MR/P hemagglutination in the absence of MR/K hemagglutination may be necessary for development of pyelonephritis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2179424     DOI: 10.1093/infdis/161.3.525

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  37 in total

1.  Cytotoxicity of the HpmA hemolysin and urease of Proteus mirabilis and Proteus vulgaris against cultured human renal proximal tubular epithelial cells.

Authors:  H L Mobley; G R Chippendale; K G Swihart; R A Welch
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

2.  complex interplay between type 1 fimbrial expression and flagellum-mediated motility of uropathogenic Escherichia coli.

Authors:  M Chelsea Lane; Amy N Simms; Harry L T Mobley
Journal:  J Bacteriol       Date:  2007-05-18       Impact factor: 3.490

3.  Structural and population characterization of MrkD, the adhesive subunit of type 3 fimbriae.

Authors:  Steen G Stahlhut; Sujay Chattopadhyay; Dagmara I Kisiela; Kristian Hvidtfeldt; Steven Clegg; Carsten Struve; Evgeni V Sokurenko; Karen A Krogfelt
Journal:  J Bacteriol       Date:  2013-10-11       Impact factor: 3.490

Review 4.  Proteus spp. as Putative Gastrointestinal Pathogens.

Authors:  Amy L Hamilton; Michael A Kamm; Siew C Ng; Mark Morrison
Journal:  Clin Microbiol Rev       Date:  2018-06-13       Impact factor: 26.132

Review 5.  Pathogenesis of Proteus mirabilis Infection.

Authors:  Chelsie E Armbruster; Harry L T Mobley; Melanie M Pearson
Journal:  EcoSal Plus       Date:  2018-02

6.  Proteus mirabilis ambient-temperature fimbriae: cloning and nucleotide sequence of the aft gene cluster.

Authors:  G Massad; J F Fulkerson; D C Watson; H L Mobley
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

7.  Development of an intranasal vaccine to prevent urinary tract infection by Proteus mirabilis.

Authors:  Xin Li; C Virginia Lockatell; David E Johnson; M Chelsea Lane; John W Warren; Harry L T Mobley
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

8.  Internalization of Proteus mirabilis by human renal epithelial cells.

Authors:  G R Chippendale; J W Warren; A L Trifillis; H L Mobley
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

9.  Proteus mirabilis amino acid deaminase: cloning, nucleotide sequence, and characterization of aad.

Authors:  G Massad; H Zhao; H L Mobley
Journal:  J Bacteriol       Date:  1995-10       Impact factor: 3.490

10.  Proteus mirabilis fimbriae: N-terminal amino acid sequence of a major fimbrial subunit and nucleotide sequences of the genes from two strains.

Authors:  F K Bahrani; S Cook; R A Hull; G Massad; H L Mobley
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.